Resources

Article Recommendation

Documents Download

Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

CD357/GITR Target

CD357/GITR (Gene ID:8784) is a member of the tumor necrosis factor receptor (TNFR) superfamily, initially discovered in the late 1990s. It is expressed predominantly a variety of immune cells, including T cells, B cells, dendritic cells, and natural killer (NK) cells. CD357/GITR is notable for its involvement in immune regulation and its potential as an immunotherapeutic target. CD357/GITR acts as a co-stimulatory receptor on T cells. Upon binding to its ligand GITRL (GITR ligand or TNFSF18), CD357/GITR enhances T cell activation and proliferation. GITRL is normally expressed on APCs. This co-stimulation contributes to the expansion of effector T cell populations. CD357/GITR is critical for the function of regulatory T cells (Tregs), which are a specialized subset of T cells responsible for suppressing suppressing immune responses and maintain immune tolerance. The signaling pathway mediated by CD357/GITR disrupts Treg suppression, leading to activation of effector T cells and enhanced immune responses. CD357/ GITR has received attention as a target for cancer immunotherapy. Activation of agonistic antibodies or ligands targeting CD357/GITR on T cells can enhance anti-tumor immune responses. The potential of combination therapies involving CD357/GITR agonists in cancer treatment is currently being investigated in preclinical and clinical studies.

 

KMD Bioscience is an innovative biotechnology company dedicated to providing high-quality CD357/GITR proteins, CD357/GITR antibodies and other high-quality target products to research institutions, universities and companies. Adhering to the principle of customer first, KMD Bioscience is committed to providing the best quality CD357/GITR related products and promoting the continuous innovation and development of the biotechnology field.

 

The featured target CD357/GITR protein products launched by KMD Bioscience:

 

CAT#

Products Name

Specise

Host

Size

Inquiry

KMPH4362

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMPH4363

Human TNFRSF18 Protein, His Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

PR257

Rat TNFRSF18 Protein, Fc Tag

Rat

HEK293 Cells

50ug, 100ug

Inquiry

KMPH5843

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMPH5844

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMPH5845

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMPH5846

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMPH5847

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMPH5848

Human TNFRSF18 Protein, Fc Tag

Human

HEK293 Cells

50ug, 100ug

Inquiry

KMH489

Recombinant Human CD357/TNFRSF18 Protein, His Tag

Human

Mammalian cells

50ug, 100ug

Inquiry

MOP2168

Recombinant Mouse Gitr/Tnfrsf18 Protein, Fc & His Tag

Mouse

Mammalian cells

50ug, 100ug

Inquiry

KMH1829

Recombinant Human TNFRSF18/GITR Protein, Fc Tag

Human

Mammalian cells

50ug, 100ug

Inquiry

 

The featured target CD357/GITR antibody products launched by KMD Bioscience:

 

CAT#

Products Name

Specise

Host

Appliance

Size

Inquiry

PA9273

Rabbit Anti-Human TNFRSF18 pAb

Human

Rabbit

WB

50ul, 100ul

Inquiry

 

Other advantageous products from KMD Bioscience: